GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients with clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, its precision oncology portfolio consists of n RUO-targeted…
$GRAL nice hold of the trendline, inside day setting up. https://t.co/p3fC4ZFK2a https://t.co/7WeUdbJk5X
$GRAL | Bull Pennant Continuation Really nice-looking chart. We had that breakaway gap, a controlled pullback into the 10/21 EMA cloud, and then a strong move higher. Now we're pulling back toward the cloud and rising trendline again. I'd like to see buyers defend this area…
Dropping 25 chart book updates for subs $AMD , $GDYN , $GEN , $GRAL, $HUBS, $IBM, $LIFE, $LLY, $LTH, $MRNA, $OXY, $PLTR, $PURR, $RBRK, $SN, $SPOT, $STNG, $TEM, $TENB, $TSLA, $ULTA, $UNH, $VG, $WDAY, $YOU https://t.co/Akfm2BWzrV
Jesus took the wheel $GRAL https://t.co/KsrC7TBmrN https://t.co/4v4P2qhmaW
$GRAL on the move again https://t.co/9MKFCVzCWQ https://t.co/FI0rXaawpd
10 analysts rate GRAL Buy on consensus.
Consensus price target: $139.44 (+40.49% upside from $99.25)
| Insider | Date | Transaction | Shares | Value |
|---|---|---|---|---|
| Freidin Aaron Chief Financial Officer | Nov 16, 2026 | Sale | 300 | $31.83K |
| Freidin Aaron Chief Financial Officer | Nov 16, 2026 | Sale | 100 | $11.25K |
| Freidin Aaron Chief Financial Officer | Nov 16, 2026 | Sale | 500 | $54.42K |
| Freidin Aaron Chief Financial Officer | Nov 16, 2026 | Sale | 1,200 | $128.94K |
| Freidin Aaron Chief Financial Officer | Nov 16, 2026 | Sale | 500 | $52.48K |
| Fiscal year | Revenue | Revenue YoY | Net income |
|---|---|---|---|
| 2025 | $147.17M | +17.18% | $-408.35M |
| 2024 | $125.6M | +34.9% | $-2.03B |
| 2023 | $93.11M | +67.61% | $-1.47B |
Stock data for GRAL: Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics